GALT - Galectin Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts2222
Avg. Estimate-0.14-0.14-0.58-0.55
Low Estimate-0.2-0.17-0.74-0.58
High Estimate-0.08-0.1-0.42-0.52
Year Ago EPS-0.12-0.11-0.38-0.58
Revenue EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts2222
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History3/30/20186/29/20189/29/201812/30/2018
EPS Est.-0.13-0.12-0.09-0.08
EPS Actual-0.12-0.11-0.07-0.08
Difference0.010.010.020
Surprise %7.70%8.30%22.20%0.00%
EPS TrendCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.14-0.14-0.58-0.55
7 Days Ago-0.14-0.14-0.58-0.55
30 Days Ago-0.14-0.17-0.71-0.76
60 Days Ago-0.19-0.23-0.98-0.98
90 Days Ago-0.19-0.23-0.98-0.98
EPS RevisionsCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/A111
Up Last 30 DaysN/A121
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1N/AN/AN/A
Growth EstimatesGALTIndustrySectorS&P 500
Current Qtr.-16.70%N/AN/A-0.01
Next Qtr.-27.30%N/AN/A0.05
Current Year-52.60%N/AN/A0.05
Next Year5.20%N/AN/A0.11
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A